Completed PHASE1 INTERVENTIONAL 2-arm NCT01241032

Phase I Study to Investigate the Alcohol Interaction of DA8159 (DA8159_DIA_I)

A Randomized, Open, Crossover Clinical Study to Investigate the Effects of Alcohol on the Pharmacokinetics of Udenafil Tablet in Healthy Male Volunteers

Sponsor: Asan Medical Center

Conditions Erectile Dysfunction Healthy Volunteers

Interventions Alcohol Udenafil

Updated 5 times since 2017 Last updated: Nov 15, 2010 Started: Jun 30, 2006 Primary completion: Feb 28, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Erectile Dysfunction and Healthy Volunteers, this trial is completed. The trial is conducted by Asan Medical Center and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jan 2017 — Jan 2021 [monthly]

Completed PHASE1

First recorded

Jun 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asan Medical Center
Dong-A Pharmaceutical Co., Ltd.

Data source: Asan Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea